Cancer treatment induced metabolic syndrome: Improving outcome with lifestyle.

@article{Westerink2016CancerTI,
  title={Cancer treatment induced metabolic syndrome: Improving outcome with lifestyle.},
  author={Niek Westerink and J Nuver and Joop Daniel Lefrandt and Aline H. Vrieling and Jourik A. Gietema and Annemiek M E Walenkamp},
  journal={Critical reviews in oncology/hematology},
  year={2016},
  volume={108},
  pages={
          128-136
        }
}
Increasing numbers of long-term cancer survivors face important treatment related adverse effects. Cancer treatment induced metabolic syndrome (CTIMetS) is an especially prevalent and harmful condition. The aetiology of CTIMetS likely differs from metabolic syndrome in the general population, but effective treatment and prevention methods are probably similar. In this review, we summarize the potential mechanisms leading to the development of CTIMetS after various types of cancer treatment… CONTINUE READING
BETA
4
Twitter Mentions

References

Publications referenced by this paper.
SHOWING 1-10 OF 83 REFERENCES

Cardiorespiratory fitness as predictor of cancer mortality: a systematic review and meta-analysis.

  • Annals of oncology : official journal of the European Society for Medical Oncology
  • 2015

Metabolic syndrome and risk of cancer: Which link

FM MendonçaFernandoMiguel
  • Metab Clin Exp
  • 2015

Recommendations for Obesity Clinical Trials in Cancer Survivors: American Society of Clinical Oncology Statement.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2015

Cardiovascular disease in survivors of adolescent and young adult cancer: A danish cohort study, 1943-2009

K. Rugbjerg Kathrine
  • JNCI: Journal of the National Cancer Institute
  • 2014

Similar Papers

Loading similar papers…